Artwork

Content provided by Breathe In: A Cystic Fibrosis Podcast, Gunnar Esiason, and The Salty Cysters. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Breathe In: A Cystic Fibrosis Podcast, Gunnar Esiason, and The Salty Cysters or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Breathe In #96 - The Triple Combo

27:53
 
Share
 

Manage episode 245807209 series 1776486
Content provided by Breathe In: A Cystic Fibrosis Podcast, Gunnar Esiason, and The Salty Cysters. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Breathe In: A Cystic Fibrosis Podcast, Gunnar Esiason, and The Salty Cysters or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A mere few days following the FDA's approval of Trikafta, cystic fibrosis patients across the United States began dosing. This week's podcast looks back at Gunnar's time in the triple combo study. Think of this podcast as a follow to Gunnar's blog over on GunnarEsiason.com. Gunnar talks about both the immediate and long term affects of having been on the medication and what his hopes are for the CF community. Gunnar and Tiffany reaffirm the scientific community's commitment to a treatment for the final 10% of CF patients and a cure for all CF patients.
  continue reading

99 episodes

Artwork
iconShare
 
Manage episode 245807209 series 1776486
Content provided by Breathe In: A Cystic Fibrosis Podcast, Gunnar Esiason, and The Salty Cysters. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Breathe In: A Cystic Fibrosis Podcast, Gunnar Esiason, and The Salty Cysters or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A mere few days following the FDA's approval of Trikafta, cystic fibrosis patients across the United States began dosing. This week's podcast looks back at Gunnar's time in the triple combo study. Think of this podcast as a follow to Gunnar's blog over on GunnarEsiason.com. Gunnar talks about both the immediate and long term affects of having been on the medication and what his hopes are for the CF community. Gunnar and Tiffany reaffirm the scientific community's commitment to a treatment for the final 10% of CF patients and a cure for all CF patients.
  continue reading

99 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide